Neurotrophin-3 improves functional constipation

American Journal of Gastroenterology

Volumn 98, Issue 6, 2003, Pages 1338-1347

  Parkman, Henry P ^a   Rao, Satish S C ^b   Reynolds, James C ^b   Schiller, Lawrence R ^b   Wald, Arnold ^b   Miner, Philip B ^b   Lembo, Anthony J ^b   Gordon, James M ^b   Drossman, Douglas A ^b   Waltzman, Lynn ^b   Stambler, Nancy ^b   Cedarbaum, Jesse M ^b  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTROPHIN 3; RECOMBINANT METHIONYL HUMAN NEUROTROPHIN 3; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFECATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FUNCTIONAL CONSTIPATION; HUMAN; INJECTION SITE; INTESTINE FUNCTION; INTESTINE TRANSIT TIME; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TISSUE REACTION;

EID: 0037973518     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.t01-1-07477.x     Document Type: Article

References (13)

1. Lindsay R, Wiegand S, Altar C, DiStefano P. Neurotrophic factors: From molecule to man. Trends Neurosci 1994;17: 182-90.
2. Chalazonitis A, Rothman TOP, Chen J, et al. Promotion of the development of enteric neurons and glia by neuropoietic cytokines: Interactions with neurotrophin-3. Dev Biol 1998;198: 343-65.
3. Chalazonitis A, Rothman TP, Chen J, Gershon MD. Age-dependent differences in the effects of GDNF and NT-3 on the development of neurons and glia from crest-derived precursors immunoselected from the fetal rat gut: Expression of GFRα-1 in vitro and in vivo. Dev Biol 1998;204:385-406.
4. Chalazonitis A, Pham TD, Rothman TP, et al. Neurotrophin-3 is required for the survival-differentiation of subsets of developing enteric neurons. J Neurosci 2001;21:5620-36.
5. Amgen-Regeneron Partners. Data on file. Thousand Oaks, CA: Amgen-Regeneron Partners.
6. Coulie B, Szarka LA, Camilleri M, et al. Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans. Gastroenterology 2000;119:41-50.
7. Drossman DA. The functional gastrointestinal disorders, 2nd editor. McLean, VA: Degnon Associates, 2000.
8. Heaton KW, Radvan J, Cripps H, et al. Defecation frequency and timing, and stool form in the general population: A prospective study. Gut 1992;33:818-24.
9. Hinton JM, Lennard-Jones JE, Young AC. A new method for studying gut transit times using radioopaque markers. Gut 1969;10:842-7.
10. De Giorgio R, Arakawa J, Wetmore CJ, Sternini C. Neurotrophin-3 and neurotrophin receptor immunoreactivity in peptidergic enteric neurons. Peptides 2000;21:1421-6.
11. Coulie B, Lee J-S, Lyford G, Camilleri M. Recombinant human neurotrophin-3 increases noncholinergic smooth muscle contractility and decreased nonadrenergic noncholinergic (NANC) inhibition of myenteric neurons in guinea pig colon. Gastroenterology 2000;118:A710 (abstract).
12. Sonnenberg A, Koch TR. Physician visits in the United States for constipation: 1958-1986. Dig Dis Sci 1989;34:606-11.
13. Bassotti G, Chiarioni G, Imbimbo BP, et al. Impaired colonic motor response to cholinergic stimulation in patients with severe chronic idiopathic (slow transit type) constipation. Dig Dis Sci 1993;38:1040-5.